Skip to main content

Maetzold Derek J's Form 4 filing

Castle Biosciences Inc (CSTL) · filed Aug 18, 2026

Accession no.
0001628280-26-057642
Filed
Aug 18, 2026, 4:09 PM ET
Trade date
Aug 14, 2026
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 8 non-derivative transactions and 1 derivative transaction. Open-market sales total $217.1K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Maetzold Derek JCIK 0001239501Director, Officer (Pres. & Chief Exec. Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 14, 2026Common StockMOption exerciseAcquired+1,100$2.39+$2,62922,579Direct
Aug 14, 2026Common StockSSaleDisposed−1,100$30.02−$33,02221,479Direct
Aug 14, 2026Common StockSSaleDisposed−2,714$30.02−$81,474.2820,355Indirect
Aug 14, 2026Common StockSSaleDisposed−2,306$30.02−$69,226.1217,301Indirect
Aug 14, 2026Common StockSSaleDisposed−278$30.02−$8,345.5611,534Indirect
Aug 14, 2026Common StockSSaleDisposed−278$30.02−$8,345.5611,534Indirect
Aug 14, 2026Common StockSSaleDisposed−278$30.02−$8,345.5611,534Indirect
Aug 14, 2026Common StockSSaleDisposed−278$30.02−$8,345.5611,534Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 14, 2026Common StockMOption exerciseDisposed−1,100$0.00$037,757Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)